CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.84 +0.00 (+0.49%)
At close: Nov 11, 2026 · 4:00 PM EST

CytoMed Therapeutics (GDTC) Amortization - Intangibles (2022 - 2026)

Updated

CytoMed Therapeutics (GDTC) recorded Amortization - Intangibles of $6,849 in Q2 2026, compared with $321.00 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Amortization - Intangibles (2022 - 2026) Analysis & Trends

For FY2025, CytoMed Therapeutics reported Amortization - Intangibles of -$29,900.

  • Across earlier years, Amortization - Intangibles came in at -$12,557 in FY2024, -$2,187 in FY2023, -$2,500 in FY2022 and -$2,512 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CytoMed Therapeutics 9.94 Mn -2.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16,353.72
Jun 30, 2025 -11,285.54
Jun 30, 2024 -1,035.52
Jun 30, 2023 -3,730.67
Jun 30, 2022 -4,798.48
API Access

CytoMed Therapeutics Amortization - Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=GDTC&period=max&api_key=YOUR_API_KEY